These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11783497)
1. Inhibition and localization of human and rat dihydroorotate dehydrogenase. Knecht W; Loffler M Adv Exp Med Biol; 2000; 486():267-70. PubMed ID: 11783497 [No Abstract] [Full Text] [Related]
2. Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid. Knecht W; Henseling J; Löffler M Chem Biol Interact; 2000 Jan; 124(1):61-76. PubMed ID: 10658902 [TBL] [Abstract][Full Text] [Related]
3. Recombinant expression of N-terminal truncated mutants of the membrane bound mouse, rat and human flavoenzyme dihydroorotate dehydrogenase. A versatile tool to rate inhibitor effects? Ullrich A; Knecht W; Fries M; Löffler M Eur J Biochem; 2001 Mar; 268(6):1861-8. PubMed ID: 11248707 [TBL] [Abstract][Full Text] [Related]
4. A preliminary characterization of the Pneumocystis carinii dihydroorotate dehydrogenase. Ittarat I; Asawamahasakda W; Meshnick SR J Eukaryot Microbiol; 1994; 41(5):92S. PubMed ID: 7804288 [No Abstract] [Full Text] [Related]
5. Dihydroorotate dehydrogenase. Profile of a novel target for antiproliferative and immunosuppressive drugs. Löffler M; Grein K; Knecht W; Klein A; Bergjohann U Adv Exp Med Biol; 1998; 431():507-13. PubMed ID: 9598119 [No Abstract] [Full Text] [Related]
6. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound. Williamson RA; Yea CM; Robson PA; Curnock AP; Gadher S; Hambleton AB; Woodward K; Bruneau JM; Hambleton P; Moss D; Thomson TA; Spinella-Jaegle S; Morand P; Courtin O; Sautés C; Westwood R; Hercend T; Kuo EA; Ruuth E J Biol Chem; 1995 Sep; 270(38):22467-72. PubMed ID: 7673235 [TBL] [Abstract][Full Text] [Related]
7. Expression, purification, and characterization of histidine-tagged rat and human flavoenzyme dihydroorotate dehydrogenase. Bader B; Knecht W; Fries M; Löffler M Protein Expr Purif; 1998 Aug; 13(3):414-22. PubMed ID: 9693067 [TBL] [Abstract][Full Text] [Related]
8. [Frequency and phase matching changes in dihydroorotate dehydrogenase activity rhythm in rat peripheral blood lymphocytes with changes in the rhythm of solar activity and planet periods]. Strigun LM; Chirkova EN; Grigor'eva GG; Bazhenova LIu Biull Eksp Biol Med; 1995 Sep; 120(9):294-8. PubMed ID: 8593343 [No Abstract] [Full Text] [Related]
9. Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium. Chen SF; Perrella FW; Behrens DL; Papp LM Cancer Res; 1992 Jul; 52(13):3521-7. PubMed ID: 1617622 [TBL] [Abstract][Full Text] [Related]
11. Redoxal as a new lead structure for dihydroorotate dehydrogenase inhibitors: a kinetic study of the inhibition mechanism. Knecht W; Löffler M FEBS Lett; 2000 Feb; 467(1):27-30. PubMed ID: 10664450 [TBL] [Abstract][Full Text] [Related]
12. Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme. Knecht W; Bergjohann U; Gonski S; Kirschbaum B; Löffler M Eur J Biochem; 1996 Aug; 240(1):292-301. PubMed ID: 8925840 [TBL] [Abstract][Full Text] [Related]
13. The mechanism of action and mode of inhibition of dihydroorotate dehydrogenase. A quantum chemical study. Mahmoudian M; Pakiari AH; Khademi S Biochem Pharmacol; 1992 Jan; 43(2):283-7. PubMed ID: 1739416 [TBL] [Abstract][Full Text] [Related]
14. Catalytic properties of dihydroorotate dehydrogenase from Saccharomyces cerevisiae: studies on pH, alternate substrates, and inhibitors. Jordan DB; Bisaha JJ; Picollelli MA Arch Biochem Biophys; 2000 Jun; 378(1):84-92. PubMed ID: 10871048 [TBL] [Abstract][Full Text] [Related]
15. Rat dihydroorotate dehydrogenase: isolation of the recombinant enzyme from mitochondria of insect cells. Knecht W; Altekruse D; Rotgeri A; Gonski S; Löffler M Protein Expr Purif; 1997 Jun; 10(1):89-99. PubMed ID: 9179295 [TBL] [Abstract][Full Text] [Related]
16. Plant dihydroorotate dehydrogenase differs significantly in substrate specificity and inhibition from the animal enzymes. Ullrich A; Knecht W; Piskur J; Löffler M FEBS Lett; 2002 Oct; 529(2-3):346-50. PubMed ID: 12372626 [TBL] [Abstract][Full Text] [Related]
17. Evidence from in vitro studies that dihydroorotate dehydrogenase may be a source of toxic oxygen species. Lakaschus G; Krüger H; Heese D; Löffler M Adv Exp Med Biol; 1991; 309A():361-4. PubMed ID: 1789244 [No Abstract] [Full Text] [Related]
18. Role of lys100 in human dihydroorotate dehydrogenase: mutagenesis studies and chemical rescue by external amines. Jiang W; Locke G; Harpel MR; Copeland RA; Marcinkeviciene J Biochemistry; 2000 Jul; 39(27):7990-7. PubMed ID: 10891080 [TBL] [Abstract][Full Text] [Related]
19. Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide. Williamson RA; Yea CM; Robson PA; Curnock AP; Gadher S; Hambleton AB; Woodward K; Bruneau JM; Hambleton P; Spinella-Jaegle S; Morand P; Courtin O; Sautés C; Westwood R; Hercend T; Kuo EA; Ruuth E Transplant Proc; 1996 Dec; 28(6):3088-91. PubMed ID: 8962196 [No Abstract] [Full Text] [Related]
20. Anti-peptide immunoglobulins from rabbit and chicken eggs recognise recombinant human dihydroorotate dehydrogenase and a 44-kDa protein from rat liver mitochondria. Knecht W; Köhler R; Minét M; Löffler M Eur J Biochem; 1996 Mar; 236(2):609-13. PubMed ID: 8612635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]